Pharmacokinetics of a water-soluble fullerene in rats

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 10, 1996, Pages 2262-2265

  Rajagopalan, Prabhu ^a   Wudl, Fred ^b   Schinazi, Raymond F ^c,d   Boudinot, F Douglas ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FULLERENE DERIVATIVE; PLASMA PROTEIN; SUCCINIMIDE DERIVATIVE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TOLERANCE; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029794180     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.10.2262     Document Type: Article

References (22)

1. 60 embedded in γ-cyclodextrin: a water soluble fullerene. J. Chem. Soc. Chem. Commun. 1992:604-606.
2. 60. J. Phys. Chem. 95:11-12.
3. 60 in model biological systems. A visible-UV absorption study of solvent-dependent parameters and solute aggregation. J. Phys. Chem. 98:3492-3500.
4. Boxenbaum, H. G., S. Riegelman, and R. M. Elashoff. 1974. Statistical estimation in pharmacokinetics. J. Pharmacokinet. Biopharm. 2:123-148.
5. Buseck, P. R., S. J. Tsipursky, and R. Hettich. 1992. Fullerenes from the geological environment. Science 257:215-217.
6. Friedman, S. H., D. L. DeCamp, R. P. Sijbesma, G. Srdanov, F. Wudl, and G. L. Kenyon. 1993. Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification. J. Am. Chem. Soc. 115:6506-6509.
7. Gerlowski, L. E., and R. K. Jain. 1983. Physiologically based pharmacokinetic modeling: principles and applications. J. Pharm. Sci. 72:1103-1126.
8. 60 into artificial lipid membranes. J. Am. Chem. Soc. 115:3386-3387.
9. 60: a new form of carbon. Nature (London) 347:354-358.
10. Metzler, D. M., G. L. Elfring, and A. J. McEwen. 1974. NONLIN, a computer program for nonlinear least-squares regression. Biometrics 30:562-563.
11. National Institutes of Health. 1986. Guide for the care and use of laboratory animals. National Institutes of Health, Washington, D.C.
12. Nelson, M. A., F. E. Domann, G. T. Bowden, S. B. Hooser, Q. Fernando, and D. E. Carter. 1993. Effects of acute and subchronic exposure of topically applied fullerene extracts on the mouse skin. Toxicol. Ind. Health 9:623-630.
13. Rocci, M. L., and W. J. Jusko. 1983. LAGRAN program for area and moments in pharmacokinetic analysis. Comp. Prog. Biomed. 16:203-216.
14. Schinazi, R. F., A. McMillan, A. S. Juodawlkis, J. Pharr, R. Sijbesma, G. Srdanov, J. C. Hummelen, F. D. Boudinot, C. L. Hill, and R. Wudl. 1994. Anti-human immunodeficiency virus, toxicity in a cell culture, and tolerance in mammals of a water-soluble fullerene, p. 689-696. In K. M. Kadish and R. S. Ruoff (ed.), Recent advances in the chemistry and physics of fullerenes and related materials. The Electrochemical Society, Pennington, N.J.
15. 60 fullerene. Antimicrob. Agents Chemother. 37:1707-1710.
16. Sijbesma, R., G. Srdanov, F. Wudl, J. A. Castoro, C. Wilkins, S. H. Friedman, D. L. DeCamp, and G. L. Kenyon. 1993. Synthesis of a fullerene derivative for the inhibition of HlV enzymes. J. Am. Chem. Soc. 115:6510-6512.
17. Tokuyama, H., S. Yamago, and E. Nakamura. 1993. Photoinduced biochemical activity of fullerene carboxylic acid. J. Am. Chem. Soc. 115:7918-7919.
18. Toniolo, C., A. Bianco, M. Maggini, G. Scorrana, M. Prato, M. Marastoni, R. Tomatis, S. Spisani, G. Palu, and E. D. Blair. 1994. A bioactive fullerene peptide. J. Med. Chem. 37:4558-4562.
19. Tsuchiya, T., Y. N. Yamakoshi, and N. Miyata. 1995. A novel promoting action of fullerene C60 on the chondrogenesis in rat embryonic limb bud cell culture system. Biochem. Biophys. Res. Commun. 206:885-894.
20. Veng-Pedersen, P. 1989. Mean time parameters in pharmacokinetics. Definition, computation and clinical implications. I. Clin. Pharmacokinet. 17:345-366.
21. Yamago, S., H. Tokuyama, E. Nakamura, K. Kikuchi, S. Kananishi, K. Sucki, H. Nakahara, S. Enomoto, and F. Ambe. 1995. In-vivo biological behavior of a water-miscible fullerene - C-14 labeling, absorption, distribution, excretion and acute toxicity. Chem. Biol. 2:385-389.
22. Yamakoshi, Y. N., T. Yagami, K. Fuhuhara, S. Sueyoshi, and N. Miyata. 1994. Solubilization of fullerenes into water with polyvinylpyrrolidone applicable to biological tests. J. Chem. Soc. Chem. Commun. 1994:517-518.